仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Encelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model （A20 cell xenograft）